XERS earnings: a negative outcome, -11.8%

On March 8, 2023, Xeris Biopharma Holdings, Inc. reached its earnings. The result was a negative outcome, and the stock moved -11.8% in the window around the event. It had already run +22.9% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.